Zafgen Reports Fourth Quarter and Full Year 2015 Financial Results
Mar 09, 2016 21:05 pm UTC| Business
BOSTON, March 09, 2016 -- Zafgen (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, today announced...
Pacific Ethanol Reports Fourth Quarter and Year-End 2015 Results
Mar 09, 2016 21:05 pm UTC| Business
– Acquisition of Midwest Assets Contributed to 4Q15 Net Sales Growth of 47% Over Prior Year and Record 4Q15 Total Gallons Sold of 213.5 Million –– GAAP Net Loss Per Share Was $0.03, Adjusted Net Income Per Share Was $0.02...
Web.com Completes Acquisition of Yodle
Mar 09, 2016 21:05 pm UTC| Business
JACKSONVILLE, Fla., March 09, 2016 -- Web.com Group, Inc. (Nasdaq:WEB), a leading provider of Internet services and online marketing solutions for small businesses, today announced it has completed the acquisition of...
Freshpet, Inc. Reports Fourth Quarter and Full Year 2015 Financial Results
Mar 09, 2016 21:05 pm UTC| Business
Fourth Quarter Net Sales Increased Approximately 23%Full Year Net Sales Increased Approximately 34%Company Provides 2016 Guidance SECAUCUS, N.J., March 09, 2016 -- Freshpet, Inc. (“Freshpet” or the “Company”)...
ISS and Glass Lewis Recommend Celladon Corporation Shareholders Vote "FOR" Proposed Merger
Mar 09, 2016 21:05 pm UTC| Business
SAN DIEGO, March 09, 2016 -- Celladon Corporation (Nasdaq:CLDN) announced today that Institutional Shareholder Services ("ISS") and Glass Lewis Co., two of the leading independent U.S. proxy advisory firms, have both...
Conatus Pharmaceuticals Reports 2015 Financial Results and Program Updates
Mar 09, 2016 21:05 pm UTC| Business
SAN DIEGO, March 09, 2016 -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced financial...
Momenta Pharmaceuticals Appoints Jose-Carlos Gutierrez-Ramos, Ph.D. to Board of Directors
Mar 09, 2016 21:05 pm UTC| Business
CAMBRIDGE, Mass., March 09, 2016 -- Momenta Pharmaceuticals,Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the appointment of...
U.S. Appeals Court Allows Trump Administration to Enforce Medicaid Funding Ban on Planned Parenthood